Your browser doesn't support javascript.
loading
A single dose of BNT162b2 vaccine elicits strong humoral response in SARS-CoV-2 seropositive individuals.
Brnjarchevska Blazhevska, Teodora; Babacic, Haris; Sibinovska, Olgica; Dobrevski, Boban; Kirijas, Meri; Milanovski, Gorjan; Arsov, Todor; Petlichkovski, Aleksandar.
Afiliação
  • Brnjarchevska Blazhevska T; Faculty of Medicine-Skopje, Institute for Immunobiology and Human Genetics, Ss. Cyril and Methodius University, Skopje, North Macedonia.
  • Babacic H; Karolinska Institute, Stockholm, Sweden.
  • Sibinovska O; Faculty of Medicine-Skopje, Institute for Immunobiology and Human Genetics, Ss. Cyril and Methodius University, Skopje, North Macedonia.
  • Dobrevski B; Faculty of Medicine-Skopje, Institute for Immunobiology and Human Genetics, Ss. Cyril and Methodius University, Skopje, North Macedonia.
  • Kirijas M; Faculty of Medicine-Skopje, Institute for Immunobiology and Human Genetics, Ss. Cyril and Methodius University, Skopje, North Macedonia.
  • Milanovski G; Faculty of Medicine-Skopje, Institute for Immunobiology and Human Genetics, Ss. Cyril and Methodius University, Skopje, North Macedonia.
  • Arsov T; Faculty of Medicine-Skopje, Institute for Immunobiology and Human Genetics, Ss. Cyril and Methodius University, Skopje, North Macedonia.
  • Petlichkovski A; John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
Allergy ; 77(1): 296-298, 2022 01.
Article em En | MEDLINE | ID: mdl-34386995

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2022 Tipo de documento: Article